Literature DB >> 12381546

Diagnostic tests for Cushing's syndrome.

Lynnette K Nieman1.   

Abstract

The diagnosis of Cushing's syndrome rests on the demonstration of clinical features and biochemical abnormalities that reflect hypercortisolism. If a patient presents with typical clinical features such as weight gain with truncal obesity and supraclavicular fat deposition, wide purple striae, and proximal muscle weakness, the diagnosis is clear-cut and is nearly always substantiated by a 24-hour urine free cortisol excretion value more than four times the normal level. However, many patients present with signs and symptoms that are common in the general population, such as hypertension, generalized weight gain, reproductive abnormalities, and depression. Many of these patients have normal cortisol excretion and do not have Cushing's syndrome. Others have mild hypercortisolism caused by psychiatric disorders, obligate exercise, morbid obesity, sleep apnea, or uncontrolled diabetes mellitus. These patients may be confused with those with the true Cushing's syndrome, and thus are considered to have a "pseudo-Cushing" state. Additional observation over time, and testing with midnight cortisol measurements, the 2-day-2-mg dexamethasone suppression test, or the dexamethasone suppression-CRH stimulation test may be useful to identify true Cushing's syndrome in these patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12381546     DOI: 10.1111/j.1749-6632.2002.tb04417.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  9 in total

1.  Host immune status influences the development of attaching and effacing lesions in weaned pigs.

Authors:  Francis Girard; Isabelle P Oswald; Ionélia Taranu; Pierre Hélie; Greg D Appleyard; Josée Harel; John M Fairbrother
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

Review 2.  Physiological basis for the etiology, diagnosis, and treatment of adrenal disorders: Cushing's syndrome, adrenal insufficiency, and congenital adrenal hyperplasia.

Authors:  Hershel Raff; Susmeeta T Sharma; Lynnette K Nieman
Journal:  Compr Physiol       Date:  2014-04       Impact factor: 9.090

3.  Quality of life in children and adolescents 1-year after cure of Cushing syndrome: a prospective study.

Authors:  Margaret F Keil; Deborah P Merke; Roma Gandhi; Edythe A Wiggs; Kathy Obunse; Constantine A Stratakis
Journal:  Clin Endocrinol (Oxf)       Date:  2008-12-17       Impact factor: 3.478

Review 4.  Hypertension and adrenal disorders.

Authors:  Wassim Chemaitilly; Robert C Wilson; Maria I New
Journal:  Curr Hypertens Rep       Date:  2003-12       Impact factor: 5.369

Review 5.  Cushing syndrome caused by adrenocortical tumors and hyperplasias (corticotropin- independent Cushing syndrome).

Authors:  Constantine A Stratakis
Journal:  Endocr Dev       Date:  2008

6.  Lower growth hormone and higher cortisol are associated with greater visceral adiposity, intramyocellular lipids, and insulin resistance in overweight girls.

Authors:  Madhusmita Misra; Miriam A Bredella; Patrika Tsai; Nara Mendes; Karen K Miller; Anne Klibanski
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-06-10       Impact factor: 4.310

7.  Severe obesity confounds the interpretation of low-dose dexamethasone test combined with the administration of ovine corticotrophin-releasing hormone in childhood Cushing syndrome.

Authors:  Dalia L Batista; Nikos Courcoutsakis; Jehan Riar; Margaret F Keil; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2008-08-26       Impact factor: 5.958

Review 8.  Cushing's disease, pseudo-Cushing states and the dexamethasone test: a historical and critical review.

Authors:  J Lindholm
Journal:  Pituitary       Date:  2014-08       Impact factor: 4.107

9.  Metabolomic Biomarkers in Urine of Cushing's Syndrome Patients.

Authors:  Alicja Kotłowska; Tomasz Puzyn; Krzysztof Sworczak; Piotr Stepnowski; Piotr Szefer
Journal:  Int J Mol Sci       Date:  2017-01-29       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.